153 related articles for article (PubMed ID: 22551880)
1. Normocalcemic hyperparathyroidism in patients with recurrent kidney stones: a disease entity or vitamin D deficiency?
Pipili C; Sekecioglu N; Oreopoulos DG
Clin Nephrol; 2012 May; 77(5):352-7. PubMed ID: 22551880
[TBL] [Abstract][Full Text] [Related]
2. Vitamin D deficiency is prevalent among idiopathic stone formers, but does correction pose any risk?
Johri N; Jaeger P; Ferraro PM; Shavit L; Nair D; Robertson WG; Gambaro G; Unwin RJ
Urolithiasis; 2017 Dec; 45(6):535-543. PubMed ID: 27981376
[TBL] [Abstract][Full Text] [Related]
3. Vitamin D status in patients with recurrent kidney stones.
Pipili C; Oreopoulos DG
Nephron Clin Pract; 2012; 122(3-4):134-8. PubMed ID: 23712072
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D deficiency and parathyroid hormone levels following renal transplantation in children.
Tuchman S; Kalkwarf HJ; Zemel BS; Shults J; Wetzsteon RJ; Foerster D; Strife CF; Leonard MB
Pediatr Nephrol; 2010 Dec; 25(12):2509-16. PubMed ID: 20872272
[TBL] [Abstract][Full Text] [Related]
5. Clinical, Biochemical, and Radiological Profile of Normocalcemic Primary Hyperparathyroidism.
Palermo A; Naciu AM; Tabacco G; Falcone S; Santonati A; Maggi D; D'Onofrio L; Briganti SI; Castellitto D; Casini A; Pedone C; Lelli D; Fabbri A; Bilezikian JP; Napoli N; Pozzilli P; Manfrini S; Cesareo R
J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32271382
[TBL] [Abstract][Full Text] [Related]
6. Effect of vitamin D repletion on urinary calcium excretion among kidney stone formers.
Leaf DE; Korets R; Taylor EN; Tang J; Asplin JR; Goldfarb DS; Gupta M; Curhan GC
Clin J Am Soc Nephrol; 2012 May; 7(5):829-34. PubMed ID: 22422535
[TBL] [Abstract][Full Text] [Related]
7. Postpartum vitamin D insufficiency and secondary hyperparathyroidism in healthy Danish women.
Møller UK; Ramlau-Hansen CH; Rejnmark L; Heickendorff L; Henriksen TB; Mosekilde L
Eur J Clin Nutr; 2006 Oct; 60(10):1214-21. PubMed ID: 16721399
[TBL] [Abstract][Full Text] [Related]
8. [Metabolic effects of Cholecalciferol supplementation in kidney stone formers with vitamin D deficiency].
Vitale C; Tricerri A; Bermond F; Fabbrini L; Guiotto C; Marangella M
G Ital Nefrol; 2018 Sep; 35(5):. PubMed ID: 30234237
[TBL] [Abstract][Full Text] [Related]
9. Vitamin D Status and Indices of Mineral Homeostasis in the Population: Differences Between 25-Hydroxyvitamin D and 1,25-Dihydroxyvitamin D.
Cirillo M; Bilancio G; Guarino E; Cavallo P; Lombardi C; Costanzo S; De Curtis A; Di Castelnuovo A; Iacoviello L
Nutrients; 2019 Aug; 11(8):. PubMed ID: 31374914
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of High vs. Conventional Ergocalciferol Dose for Increasing 25-Hydroxyvitamin D and Suppressing Parathyroid Hormone Levels in Stage III-IV CKD with Vitamin D Deficiency/Insufficiency: A Randomized Controlled Trial.
Thimachai P; Supasyndh O; Chaiprasert A; Satirapoj B
J Med Assoc Thai; 2015 Jul; 98(7):643-8. PubMed ID: 26267985
[TBL] [Abstract][Full Text] [Related]
11. Parathyroid hormone reference ranges in healthy individuals classified by vitamin D status.
Yalla N; Bobba G; Guo G; Stankiewicz A; Ostlund R
J Endocrinol Invest; 2019 Nov; 42(11):1353-1360. PubMed ID: 31273631
[TBL] [Abstract][Full Text] [Related]
12. Effect of vitamin D supplementation on 24-hour urine calcium in patients with calcium Urolithiasis and vitamin D deficiency.
Taheri M; Tavasoli S; Shokrzadeh F; Amiri FB; Basiri A
Int Braz J Urol; 2019; 45(2):340-346. PubMed ID: 30735332
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D deficiency, parathyroid hormone levels, and bone disease among patients with end-stage liver disease and normal serum creatinine awaiting liver transplantation.
Corey RL; Whitaker MD; Crowell MD; Keddis MT; Aqel B; Balan V; Byrne T; Carey E; Douglas DD; Harrison ME; Vargas HE; Rakela J
Clin Transplant; 2014 May; 28(5):579-84. PubMed ID: 24628047
[TBL] [Abstract][Full Text] [Related]
14. Parathormone, vitamin D and the risk of atrial fibrillation in older adults: A prospective study.
Trevisan C; Piovesan F; Lucato P; Zanforlini BM; De Rui M; Maggi S; Noale M; Corti MC; Perissinotto E; Manzato E; Sergi G
Nutr Metab Cardiovasc Dis; 2019 Sep; 29(9):939-945. PubMed ID: 31303477
[TBL] [Abstract][Full Text] [Related]
15. Data mining: Biological and temporal factors associated with blood parathyroid hormone, vitamin D, and calcium concentrations in the Southwestern Chinese population.
Ding F; Nie X; Li X; He Y; Li G
Clin Biochem; 2021 Apr; 90():50-57. PubMed ID: 33539806
[TBL] [Abstract][Full Text] [Related]
16. Failure to normalize parathyroid hormone during treatment of vitamin D deficiency in Asian patients.
Peacey SR; Wright D; Harries MJ
Clin Endocrinol (Oxf); 2004 Nov; 61(5):603-6. PubMed ID: 15521963
[TBL] [Abstract][Full Text] [Related]
17. Unsuppressed parathyroid hormone in patients with autoimmune/inflammatory rheumatic diseases: implications for vitamin D supplementation.
Sainaghi PP; Bellan M; Antonini G; Bellomo G; Pirisi M
Rheumatology (Oxford); 2011 Dec; 50(12):2290-6. PubMed ID: 22019806
[TBL] [Abstract][Full Text] [Related]
18. Vitamin D, Hypercalciuria and Kidney Stones.
Letavernier E; Daudon M
Nutrients; 2018 Mar; 10(3):. PubMed ID: 29562593
[TBL] [Abstract][Full Text] [Related]
19. Urinary calcium excretion in primary hyperparathyroidism: relationship to 25-hydroxyvitamin d status.
Bussey AD; Bruder JM
Endocr Pract; 2005; 11(1):37-42. PubMed ID: 16033734
[TBL] [Abstract][Full Text] [Related]
20. Calcium and phosphorus regulatory hormones and risk of incident symptomatic kidney stones.
Taylor EN; Hoofnagle AN; Curhan GC
Clin J Am Soc Nephrol; 2015 Apr; 10(4):667-75. PubMed ID: 25623233
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
